Performance of a rapid antigen test for SARS-CoV-2 in Kenya

Simon Onsongo(Aga Khan Hospital, Kisumu), Tobias F. Rinke de Wit(Amsterdam Institute for Global Health and Development), Simon Kariuki(Kamuzu Central Hospital), Nathalie Houben(PharmAccess Group), Shannen van Duijn(University of Amsterdam), Robert Aroka(PharmAccess Group), Fredrick Oluoch(Great Lakes University of Kisumu), Emmanuel Milimo(PharmAccess Group), Emily R. Adams(Liverpool School of Tropical Medicine), Hellen C. Barsosio(Liverpool School of Tropical Medicine), Isdora A. Odero(Kenya Medical Research Institute), Kephas Otieno(Kenya Medical Research Institute), Alloys K’Oloo(Kenya Medical Research Institute), Mervis Omollo(Kenya Medical Research Institute), Albert Odhiambo(Great Lakes University of Kisumu)
Diagnostic Microbiology and Infectious Disease
November 1, 2021
10.1016/j.diagmicrobio.2021.115591
Cited by 20

Related Papers

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya
|Nature Microbiology|2016|114
Health disparities across the counties of Kenya and implications for policy makers, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Global Health|2018|105
Achieving accurate estimates of fetal gestational age and personalised predictions of fetal growth based on data from an international prospective cohort study: a population-based machine learning study
|The Lancet Digital Health|2020|79
Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial
|The Lancet|2023|72